Xenon Pharmaceuticals Inc.XENENASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-235.86M
↓ 189% below average
Average (9y)
$-81.48M
Historical baseline
Range
High:$-8.32M
Low:$-235.86M
CAGR
+45.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-235.86M | -12.0% |
| 2023 | $-210.51M | -64.8% |
| 2022 | $-127.74M | -63.6% |
| 2021 | $-78.09M | -179.2% |
| 2020 | $-27.97M | +29.7% |
| 2019 | $-39.76M | -22.2% |
| 2018 | $-32.54M | -8.3% |
| 2017 | $-30.05M | -25.5% |
| 2016 | $-23.95M | -187.8% |
| 2015 | $-8.32M | - |